Evidence map›Paper›PMID 40823833›Full record

ArticlemBio2025

Rapid, low-cost colorimetric detection of

Kesia Esther da Silva, Tuya Yokoyama, Shiva Ram Naga, Mamata Maharjan, Paulo César Pereira Dos Santos, Karla N Fisher, Jean T Coulibaly, Max Zhang Yang, Eric Jorge Nelson, Richelle C Charles and 9 more

Abstract readEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. A two-year study ofApplied and environmental microbiology · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Kesia Esther da SilvaDepartment of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA.ORCID 0000-0001-8593-1119
Tuya YokoyamaDepartment of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA.
Shiva Ram NagaCentre of Infectious Disease Research and Surveillance, Dhulikhel Hospital, Kathmandu University Hospital, Kavre, Nepal.
Mamata MaharjanCentre of Infectious Disease Research and Surveillance, Dhulikhel Hospital, Kathmandu University Hospital, Kavre, Nepal.
Paulo César Pereira Dos SantosSchool of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.
Karla N FisherDivision of Infectious Diseases, Toronto General Hospital, University Health Network, Toronto, Canada.
Jean T CoulibalyUnité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, Abidjan, Côte d'Ivoire.
Max Zhang YangDepartment of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA.
Eric Jorge NelsonDepartments of Pediatrics and Environmental and Global Health, University of Florida, Gainesville, Florida, USA.ORCID 0000-0003-2649-2624
Richelle C CharlesDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-8881-1849
Katherine ShaferDépartement de Chirurgie, Hôpital de la SIM, Galmi, Niger.
Brad-Lot IgiranezaDépartement de Chirurgie, Hôpital de la SIM, Galmi, Niger.
Samaila YusufDépartement de Chirurgie, Hôpital de la SIM, Galmi, Niger.
Elisabeth MulderOregon Health & Science University, Portland, Oregon, USA.
Kathleen NeuzilFogarty International Center, National Institutes of Health, Bethesda, Maryland, USA.
Isaac I BogochDepartment of Medicine, Division of Infectious Diseases, University of Toronto, Toronto, Canada.
Rajeev ShresthaCentre of Infectious Disease Research and Surveillance, Dhulikhel Hospital, Kathmandu University Hospital, Kavre, Nepal.
Dipesh TamrakarCentre of Infectious Disease Research and Surveillance, Dhulikhel Hospital, Kathmandu University Hospital, Kavre, Nepal.
Jason R AndrewsDepartment of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA.ORCID 0000-0002-5967-251X

Funding

Novel tools for measuring typhoid vaccine impactR01AI181283 · NIAID · STANFORD UNIVERSITY · PI Jason Randolph Andrews, Richelle C Charles · 2024 to 2026
$2.2M
Bill and Melinda Gates Foundation OPP 1217093NIAID NIH HHS R01 AI181283Stanford Center for Innovation in Global Health
6 · The paper itself

Abstract

Typhoid fever remains a global public health challenge, especially in low- and middle-income countries where poor sanitation and limited access to clean water facilitate transmission. The lack of data on disease burden poses a significant barrier to adopting effective interventions such as vaccination programs. We developed a novel colorimetric assay for the detection of IMPORTANCE: Typhoid fever, caused by

Indexed as

ColorimetryEnvironmental MonitoringSalmonella PhagesSalmonella typhiCote d'IvoireHumansNepalSensitivity and SpecificityTyphoid FeverWater Microbiologybacteriophagesenteric feverenvironmental surveillancelow-cost assaySalmonella Typhityphoid

Identifiers

PMID40823833
PMCPMC12421811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.